$0.5800
0.009801.72%
At close: -
$0.5795
-0.00050-0.09%
After Hours: Apr 23, 8:05 AM EDT
Comments
Loading...
NovaBay Pharmaceuticals Earnings Estimates, EPS & Revenue | AMEX:NBY | Benzinga
NovaBay Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.240
Quarterly Revenue Estimate
$3.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$9.78M
Analyze the earnings history of NovaBay Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals | -$4.90 | -$0.24 | — | — | $2.63M | $3.00M | — | — | 05/08/2025 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$7.35 | -$0.24 | — | — | $3.73M | $3.00M | — | — | 04/02/2025 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$13.11 | -$0.30 | -$0.60 | -100.00% | $2.48M | $2.62M | $2.44M | -6.94% | 11/07/2024 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$44.43 | -$1.23 | -$1.37 | -11.38% | $3.53M | $3.15M | $2.40M | -23.81% | 08/13/2024 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$23.10 | -$5.25 | -$4.90 | 6.67% | $2.34M | $3.28M | $2.63M | -19.79% | 05/09/2024 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$51.45 | -$10.50 | -$7.35 | 30.00% | $3.64M | $3.40M | $3.73M | 9.62% | 03/26/2024 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$122.50 | -$14.00 | -$12.95 | 7.50% | $3.83M | $3.55M | $3.27M | -8.03% | 11/09/2023 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$49.00 | -$19.25 | -$44.45 | -130.91% | $3.04M | $3.67M | $4.61M | 25.61% | 08/10/2023 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$61.25 | -$31.85 | -$29.75 | 6.59% | $3.27M | $3.20M | $3.12M | -2.37% | 05/11/2023 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$147.00 | -$5.95 | -$51.45 | -764.71% | $2.64M | $5.10M | $3.64M | -28.57% | 03/30/2023 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$61.25 | -$36.75 | -$122.50 | -233.33% | $1.84M | $3.75M | $3.83M | 2.03% | 11/14/2022 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$49.00 | -$36.75 | -$49.00 | -33.33% | $2.13M | $3.51M | $3.04M | -13.25% | 08/11/2022 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$49.00 | -$36.75 | -$61.25 | -66.67% | $1.81M | $3.26M | $2.63M | -19.36% | 05/12/2022 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$49.00 | -$61.25 | -$147.00 | -140.00% | $1.89M | $3.34M | $2.64M | -21.08% | 03/29/2022 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$98.00 | -$36.75 | -$61.25 | -66.67% | $2.17M | $3.44M | $1.84M | -46.51% | 11/11/2021 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$183.75 | -$49.00 | -$49.00 | 0.00% | $3.98M | — | $2.13M | — | 08/12/2021 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$73.50 | -$49.00 | -$49.00 | 0.00% | $1.89M | $2.34M | $1.81M | -22.78% | 05/06/2021 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$159.25 | -$49.00 | -$49.00 | 0.00% | $1.70M | $2.48M | $1.89M | -23.87% | 03/25/2021 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$24.50 | -$49.00 | -$98.00 | -100.00% | $1.61M | $2.52M | $2.17M | -13.89% | 11/12/2020 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$171.50 | -$61.25 | -$183.75 | -200.00% | $1.79M | $2.85M | $3.98M | 39.79% | 08/06/2020 | Get Alert |
| NBY | NovaBay Pharmaceuticals | -$343.00 | -$85.75 | -$73.50 | 14.29% | $1.49M | $2.09M | $1.89M | -9.47% | 05/07/2020 | Get Alert |
NovaBay Pharmaceuticals (NBY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.60 | $-0.30 | -100.0 % |
| Q2 | 2024-08-13 | $-1.37 | $-1.23 | -11.4 % |
| Q1 | 2024-05-09 | $-4.90 | $-5.25 | 6.67 % |
| Q4 | 2024-03-26 | $-7.35 | $-10.50 | 30.0 % |
NovaBay Pharmaceuticals (NBY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $2.44M | $2.62M | -6.94 % |
| Q2 | 2024-08-13 | $2.40M | $3.15M | -23.8 % |
| Q1 | 2024-05-09 | $2.63M | $3.28M | -19.8 % |
| Q4 | 2024-03-26 | $3.73M | $3.40M | 9.62 % |
FAQ
When is NovaBay Pharmaceuticals (AMEX:NBY) reporting earnings?
NovaBay Pharmaceuticals (NBY) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on April 2, 2025 for Q4.
What were the latest earnings per share (EPS) for NovaBay Pharmaceuticals (AMEX:NBY)?
The Actual EPS was $0.00, which beat the estimate of $-0.24.
What were NovaBay Pharmaceuticals’s (AMEX:NBY) revenues?
The Actual Revenue was $0K, which missed the estimate of $3M.
Browse earnings estimates, EPS, and revenue on all stocks.
